cannabinoids - CISMeF

Preferred Label : cannabinoids;

MeSH definition : Compounds having the cannabinoid structure. They were originally extracted from Cannabis sativa L. The most pharmacologically active constituents are TETRAHYDROCANNABINOL; CANNABINOL; and CANNABIDIOL.;

MeSH synonym : Cannabinoid;

MeSH annotation : endogenous list less /aa/defic;

Wikipedia link : https://en.wikipedia.org/wiki/Cannabinoid;

Is substance : O;

Details

Origin ID

D002186;

UMLS CUI

C0006864;

ATC code(s)
- cannabinoids [ATC Code]
ATC code(s)
- cannabinoids [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Cannabinoids [ICD-11 Extension code]
- Cannabinoids & hallucinogens [ICHI section]
- cannabinoids [EMDN type]
- cannabinoids [medical devices type]
Currated CISMeF NLP mapping
- Cannabinoid [NCIt concept]
- Cannabinoid (substance) [SNOMED CT concept]
- Cannabinoids [LOINC component]
- Cannabinoids [MedDRA LLT]
- Cannabis (derivatives) [ICD-11 Extension code]
- Marijuana derivative (product) [Inactive SNOMED CT concept]
- marihuana derivative [SNOMED Notion]
Indexing information
- (1-pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone [MeSH Supplementary Concept]
- (3R)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone [MeSH Supplementary Concept]
- 2-methylarachidonyl-2'-fluoroethylamide [MeSH Supplementary Concept]
- 3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol [MeSH Supplementary Concept]
- CP 47497 [MeSH Supplementary Concept]
- nabiximols [MeSH Supplementary Concept]
Record concept(s)
- cannabinoids [MeSH concept]
Related MeSH Supplementary Concept(s)
- (1RS,3SR)-3-(4-(1,1-dimethyloctyl)-2-hydroxyphenyl)cyclohexan-1-ol [MeSH Supplementary Concept]
- 1,1-dimethylbutyl-1-deoxy-Delta(9)-THC [MeSH Supplementary Concept]
- 2-(4-methoxyphenyl)-1-(1-pentyl-indol-3-yl)methanone [MeSH Supplementary Concept]
- 3-peroxyeucannabinolide [MeSH Supplementary Concept]
- 4-acetoxy-2-geranyl-5-hydroxy-3-n-pentylphenol [MeSH Supplementary Concept]
- 5-acetyl-4-hydroxycannabigerol [MeSH Supplementary Concept]
- 5F-ADB cannabinoid [MeSH Supplementary Concept]
- 5F-CUMYL-P7AICA [MeSH Supplementary Concept]
- 5F-MDMB-PICA [MeSH Supplementary Concept]
- 6a,7,10,10a-tetrahydro-1-hydroxy-6,6-dimethyl-3-pentyl-6H-dibenzo(b,d)pyran-9(8H)-one [MeSH Supplementary Concept]
- 7'N-5F-ADB [MeSH Supplementary Concept]
- 8-hydroxycannabinol [MeSH Supplementary Concept]
- AM 1241 [MeSH Supplementary Concept]
- AMG 18 [MeSH Supplementary Concept]
- AMG 3 [MeSH Supplementary Concept]
- APP-CHMINACA [MeSH Supplementary Concept]
- C(11)-methyl-hexahydrocannabinol [MeSH Supplementary Concept]
- CUMYL-PEGACLONE [MeSH Supplementary Concept]
- Cumyl-CBMICA [MeSH Supplementary Concept]
- Cumyl-CBMINACA [MeSH Supplementary Concept]
- FDU-PB-22 [MeSH Supplementary Concept]
- HU 243 [MeSH Supplementary Concept]
- HU 308 [MeSH Supplementary Concept]
- HU-580 [MeSH Supplementary Concept]
- KM-233 [MeSH Supplementary Concept]
- MDMB-4en-PINACA [MeSH Supplementary Concept]
- MDMB-CHMINACA [MeSH Supplementary Concept]
- O 1057 [MeSH Supplementary Concept]
- PrNMI [MeSH Supplementary Concept]
- THJ-018 [MeSH Supplementary Concept]
- URB937 [MeSH Supplementary Concept]
- VCE-003 [MeSH Supplementary Concept]
- XLR-11 [MeSH Supplementary Concept]
- amorphastilbol [MeSH Supplementary Concept]
- cannabichromene [MeSH Supplementary Concept]
- cannabicyclol [MeSH Supplementary Concept]
- cannabidiolic acid [MeSH Supplementary Concept]
- cannabidivarin [MeSH Supplementary Concept]
- cannabidivarinic acid [MeSH Supplementary Concept]
- cannabigerol [MeSH Supplementary Concept]
- cannabinerol (CBNR) [MeSH Supplementary Concept]
- cannabinoid K2 [MeSH Supplementary Concept]
- cannabinor [MeSH Supplementary Concept]
- cannabisativine [MeSH Supplementary Concept]
- cannabitriol [MeSH Supplementary Concept]
- cannabivarichromene [MeSH Supplementary Concept]
- cannabivarin [MeSH Supplementary Concept]
- delta(9)-tetrahydrocannabivarinic acid [MeSH Supplementary Concept]
- methyl (1-(5-fluoropentyl)-1H-indazole-3-carbonyl)valinate [MeSH Supplementary Concept]
- ranhuadujuanine A [MeSH Supplementary Concept]
- sesquicannabigerol [MeSH Supplementary Concept]
- virodhamine [MeSH Supplementary Concept]
See also
- cannabinoid receptor agonists [MeSH Descriptor]
- cannabis [MeSH Descriptor]
- receptors, cannabinoid [MeSH Descriptor]
See also (suggested by CISMeF)
- hallucinogens [MeSH Descriptor]
- medical marijuana [MeSH Descriptor]
See also inter- (CISMeF)
- Cannabinoid Drug Class Measurement [NCIt concept]
- Cannabinoids tested for [LOINC component]
- Cannabis (substance) [SNOMED CT concept]
- Product containing cannabinoid (product) [SNOMED CT concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Cannabinoid [NCIt concept]
- Cannabinoid (substance) [SNOMED CT concept]
- Cannabinoids [LOINC component]
- Product containing cannabinoid (product) [SNOMED CT concept]
- cannabinoids [ATC Code]
Validated automatic mappings to BTNT
- cannabinoids [ATC Code]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients